AMRN

Dopo l'orario di chiusura: 15.00

Amarin Corp Adr (AMRN)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Amarin Corp Adr Stock (AMRN) Company Profile

Amarin Corp Adr

Healthcare (1161)

353 1 6699 020

SPACES SOUTH DOCKLANDS, BLOCK C, DUBLIN 2

Prossima data di guadagno

Ultimi documenti SEC

AMRN's Discussions on Twitter

Confronta AMRN con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
AMRN Amarin Corp Adr	15.00	309.00M	306.91M	-59.11M	6.35M	-0.15
LLY Lilly Eli Co	660.49	569.45B	53.26B	13.80B	-50.20M	15.30
JNJ Johnson Johnson	174.42	418.62B	90.63B	22.66B	16.40B	9.35
ABBV Abbvie Inc	201.47	350.91B	58.33B	3.76B	18.24B	2.10
NVS Novartis Ag Adr	121.20	229.50B	55.19B	13.65B	16.81B	6.86
MRK Merck Co Inc	82.71	199.90B	63.62B	16.41B	14.72B	6.49

Amarin Corp Adr Stock (AMRN) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2023-11-20	Ripresa	JP Morgan	Underweight
2023-10-25	Downgrade	Jefferies	Buy → Hold
2023-01-06	Aggiornamento	Jefferies	Hold → Buy
2022-05-06	Downgrade	JP Morgan	Neutral → Underweight
2022-05-05	Downgrade	H.C. Wainwright	Buy → Neutral
2022-05-05	Downgrade	SVB Leerink	Outperform → Mkt Perform
2022-05-04	Downgrade	Northland Capital	Outperform → Market Perform
2021-05-12	Downgrade	Goldman	Neutral → Sell
2020-09-29	Ripresa	JP Morgan	Neutral
2020-08-26	Iniziato	Piper Sandler	Overweight
2020-05-05	Iniziato	Northland Capital	Outperform
2020-03-31	Downgrade	Goldman	Buy → Neutral
2020-03-31	Downgrade	Jefferies	Buy → Hold
2020-03-31	Aggiornamento	Oppenheimer	Underperform → Perform
2020-03-13	Aggiornamento	Goldman	Neutral → Buy
2020-03-02	Iniziato	Cowen	Outperform
2020-02-18	Aggiornamento	Citigroup	Neutral → Buy
2020-01-06	Iniziato	JP Morgan	Neutral
2019-12-16	Downgrade	Stifel	Buy → Hold
2019-11-20	Iniziato	Oppenheimer	Underperform
2019-11-18	Downgrade	Citigroup	Buy → Neutral
2019-11-15	Reiterato	SVB Leerink	Outperform
2019-10-31	Iniziato	Aegis Capital	Buy
2019-10-15	Iniziato	Goldman	Neutral
2019-08-14	Iniziato	SVB Leerink	Outperform
2019-07-09	Reiterato	Jefferies	Buy
2019-06-17	Iniziato	ROTH Capital	Buy
2019-03-22	Iniziato	Stifel	Buy

Mostra tutto

Amarin Corp Adr Borsa (AMRN) Ultime notizie

Amarin Corp Adr Azioni (AMRN) Dati Finanziari

Amarin Corp Adr (AMRN)

Amarin Corp Adr Stock (AMRN) Company Profile

Confronta AMRN con altri titoli

Amarin Corp Adr Stock (AMRN) Upgrades & Downgrades

Amarin Corp Adr Borsa (AMRN) Ultime notizie

Amarin's Q2 Earnings & Revenues Trump Estimates, Stock Rises - Barchart.com

Amarin Gears Up To Report Q2 Earnings: Here's What To Expect - Barchart.com

VKTX Stock Down On Wider-Than-Expected Loss In Q2, Nil Sales - Barchart.com

Zacks.com featured highlights include Mama's Creations, Bassett Furniture Industries and Amarin - Barchart.com

KRYS Begins Dosing With Gene Therapy In Rare Eye Disease, Stock Up - Barchart.com

RYTM Stock Rises On Upbeat Acquired Hypothalamic Obesity Study Data - Barchart.com

PROK Surges More Than 500% On Upbeat Data From Kidney Cell Therapy Study - Barchart.com

Amarin Soars 27% on Vazkepa Licensing Deal With Recordati in the EU - Yahoo Finance

Amarin licenses VAZKEPA to Recordati in 59 European countries - Investing.com

Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

KURA Stock Rises More Than 15% This Past Week: Here's Why - Barchart.com

Is GSK PLC Sponsored ADR (GSK) Outperforming Other Medical Stocks This Year? - Yahoo Finance

RCKT Stock Tanks On Patient Death In Danon Disease Study - Barchart.com

SpringWorks Gets CHMP Nod For Mirdametinib In Rare Disease - Barchart.com

Amarin's Q1 Earnings Beat Estimates, Revenues Decline Y/Y - Barchart.com

Amarin earnings beat by $0.04, revenue topped estimates - Investing.com

Amarin to Report First Quarter 2025 Financial Results and Host Conference Call on May 7, 2025 - Barchart.com

Press Release Distribution & PR Platform - ACCESS Newswire

Looking For A Top Momentum Stock? Check Out Amarin Corp ADR (NASDAQ: AMRN) - Stocksregister

Amarin Takes Critical Step to Avoid Nasdaq Delisting with 1-for-20 Share Consolidation - Stock Titan

Amarin announces ADS ratio change to meet Nasdaq requirements - Investing.com

Major Shake-up: Investment Firm Leader Joins Amarin Board to Drive Shareholder Value - Stock Titan

Amarin adds investment expert Michael Torok to Board By Investing.com - Investing.com

Upcoming Stock Splits This Week (April 7 to April 11) – Stay Invested - markets.businessinsider.com

A Look at New Gold Inc (NGD) Shares in the Recent Past Indicates Growth - Sete News

Breakthrough: EPA Treatment Shows Double Impact on Heart Disease When Combined with Popular Diabetes Drug - Stock Titan

Amarin announces board member departure ahead of annual meeting - Investing.com

European Equities Traded in the US as American Depositary Receipts Higher in Monday Trading - TradingView

European Equities Traded in the US as American Depositary Receipts Track Lower in Wednesday Trading - TradingView

Amarin urged to review strategy by major shareholders - Investing.com

Assessing the Risk and Potential of Sempra’s (SRE) Stock - The News Heater

Amarin Corporation plc (NASDAQ:AMRN) Q4 2024 Earnings Call Transcript - Insider Monkey

Amarin Corp PLC (AMRN) Q4 2024 Earnings Call Highlights: Navigating Challenges and Expanding ... - Yahoo Finance

Amarin Plc (AMRN) Q4 2024 Earnings Call Transcript - The Motley Fool

Amarin announce splan to initiate ratio change under ADR program - TipRanks

Amarin Announces Plan to Initiate a Ratio Change Under Its American Depository Receipt (ADR) Program - The Manila Times

Amarin Corp. (AMRN) Announces 1-For-20 ADS Ratio Change to Maintain Nasdaq Listing - StreetInsider.com

Amarin Plans Major ADR Restructuring: What This 1:20 Ratio Change Means for Investors - StockTitan

Amarin Announces 1-for-20 Reverse Stock Split - TipRanks

How Amarin's Latest European Reimbursement Victory Strengthens Its Cardiovascular Market Position - Stock Titan

Will Amarin's Q4 Earnings Mark a Turning Point? Key Date and Details Revealed - Stock Titan

Amarin Corp ADR (AMRN) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - SETE News

European Equities Traded in the US as American Depositary Receipts Tread Water in Wednesday Trading - TradingView

Amarin stock touches 52-week low at $0.45 amid challenges - Investing.com

Italy grants VAZKEPA reimbursement for heart risk - Investing.com

Amarin appoints new chief financial officer - Investing.com

Amarin stock plunges to 52-week low of $0.46 amid challenges - Investing.com

Amarin granted extension to meet Nasdaq listing standards - Investing.com

Top 3 Health Care Stocks You'll Regret Missing In Q4Amarin Corp (NASDAQ:AMRN) - Benzinga

Amarin stock touches 52-week low at $0.55 amid market challenges - Investing.com

Amarin to present new cardiovascular research at ESC Congress - Investing.com

Amarin Corp Adr Azioni (AMRN) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a AMRN